324 related articles for article (PubMed ID: 29440272)
1. Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.
Fahey JM; Stancill JS; Smith BC; Girotti AW
J Biol Chem; 2018 Apr; 293(14):5345-5359. PubMed ID: 29440272
[TBL] [Abstract][Full Text] [Related]
2. Upstream signaling events leading to elevated production of pro-survival nitric oxide in photodynamically-challenged glioblastoma cells.
Fahey JM; Korytowski W; Girotti AW
Free Radic Biol Med; 2019 Jun; 137():37-45. PubMed ID: 30991141
[TBL] [Abstract][Full Text] [Related]
3. Negative effects of tumor cell nitric oxide on anti-glioblastoma photodynamic therapy.
Girotti AW; Fahey JM; Korytowski W
J Cancer Metastasis Treat; 2020; 6():. PubMed ID: 33564720
[TBL] [Abstract][Full Text] [Related]
4. Enhanced aggressiveness of bystander cells in an anti-tumor photodynamic therapy model: Role of nitric oxide produced by targeted cells.
Bazak J; Fahey JM; Wawak K; Korytowski W; Girotti AW
Free Radic Biol Med; 2017 Jan; 102():111-121. PubMed ID: 27884704
[TBL] [Abstract][Full Text] [Related]
5.
Nord JA; Wynia-Smith SL; Gehant AL; Jones Lipinski RA; Naatz A; Rioja I; Prinjha RK; Corbett JA; Smith BC
Front Endocrinol (Lausanne); 2022; 13():923925. PubMed ID: 36176467
[TBL] [Abstract][Full Text] [Related]
6. Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress.
Bhowmick R; Girotti AW
Free Radic Biol Med; 2013 Apr; 57():39-48. PubMed ID: 23261943
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
Fahey JM; Girotti AW
Nitric Oxide; 2017 Jan; 62():52-61. PubMed ID: 28007662
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model.
Fahey JM; Emmer JV; Korytowski W; Hogg N; Girotti AW
Photochem Photobiol; 2016 Nov; 92(6):842-853. PubMed ID: 27608331
[TBL] [Abstract][Full Text] [Related]
9. Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.
Fahey JM; Girotti AW
Nitric Oxide; 2015 Sep; 49():47-55. PubMed ID: 26068242
[TBL] [Abstract][Full Text] [Related]
10. Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor κB (NF-κB) signaling.
Wu X; Qi J; Bradner JE; Xiao G; Chen LF
J Biol Chem; 2013 Dec; 288(50):36094-105. PubMed ID: 24189064
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of pro-tumor nitric oxide by anti-tumor photodynamic therapy.
Girotti AW; Fahey JM
Biochem Pharmacol; 2020 Jun; 176():113750. PubMed ID: 31836386
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of BET bromodomain targets genetically diverse glioblastoma.
Cheng Z; Gong Y; Ma Y; Lu K; Lu X; Pierce LA; Thompson RC; Muller S; Knapp S; Wang J
Clin Cancer Res; 2013 Apr; 19(7):1748-59. PubMed ID: 23403638
[TBL] [Abstract][Full Text] [Related]
13. BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1.
Stewart HJ; Horne GA; Bastow S; Chevassut TJ
Cancer Med; 2013 Dec; 2(6):826-35. PubMed ID: 24403256
[TBL] [Abstract][Full Text] [Related]
14. Nitric Oxide Antagonism to Anti-Glioblastoma Photodynamic Therapy: Mitigation by Inhibitors of Nitric Oxide Generation.
Fahey JM; Girotti AW
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781428
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.
Hölscher AS; Schulz WA; Pinkerneil M; Niegisch G; Hoffmann MJ
Clin Epigenetics; 2018; 10():1. PubMed ID: 29312470
[TBL] [Abstract][Full Text] [Related]
16. Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy.
Girotti AW; Fahey JM; Korytowski W
Curr Med Chem; 2016; 23(24):2754-2769. PubMed ID: 27776475
[TBL] [Abstract][Full Text] [Related]
17. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.
Jung M; Philpott M; Müller S; Schulze J; Badock V; Eberspächer U; Moosmayer D; Bader B; Schmees N; Fernández-Montalván A; Haendler B
J Biol Chem; 2014 Mar; 289(13):9304-19. PubMed ID: 24497639
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide-elicited resistance to anti-glioblastoma photodynamic therapy.
Girotti AW; Fahey JM; Korytowski W
Cancer Drug Resist; 2020 3rd Quarter; 3(3):401-414. PubMed ID: 33073206
[TBL] [Abstract][Full Text] [Related]
19. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells.
Khan YM; Kirkham P; Barnes PJ; Adcock IM
PLoS One; 2014; 9(4):e95051. PubMed ID: 24759736
[TBL] [Abstract][Full Text] [Related]
20. Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA.
Zou Z; Huang B; Wu X; Zhang H; Qi J; Bradner J; Nair S; Chen LF
Oncogene; 2014 May; 33(18):2395-404. PubMed ID: 23686307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
